\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\:\\ \\ general\\ \\-\\ this\\ is\\ a\\ slightly\\ emaciated\\ african\\-american\\ male\\ who\\ appears\\ dehydrated\\.\\ \\ \ \(0\)\
\-\ vital\\ signs\\ \\-\\ afebrile\\.\\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ temperature\\ 97\\.4\\,\\ blood\\ pressure\\ 112\\/87\\,\\ pulse\\ 98\\,\\ respiratory\\ rate\\ 18\\.\ \(0\)\
\-\ the\\ patient\\ was\\ admitted\\ and\\ treated\\ with\\ ceftriaxone\\ and\\ zithromax\\ for\\ a\\ respiratory\\ tract\\ infection\\.\\ after\\ two\\ days\\ and\\ multiple\\ breathing\\ treatments\\ the\\ patient\\ was\\ encouraged\\ to\\ stop\\ smoking\\ as\\ quickly\\ possible\\ and\\ discharged\\ home\\.\ \(0\)\
\-\ findings\\ compatible\\ with\\ pulmonary\\ artery\\ hypertension\\ and\\ chronic\\ obstructive\\ pulmonary\\ disease\\.\ \(0\)\
\-\ pulmonary\\ arterial\\ hypertension\ \(11\)\
\-\ differential\\ diagnosis\\ of\\ enlarged\\ hila\ \(0\)\
\-\ \\Â\\·\\ adenopathy\\ \\(sarcoidosis\\,\\ lymphoma\\,\\ infection\\,\\ neoplasm\\)\ \(0\)\
\-\ \\Â\\·\\ malignancy\\ \\(primary\\ or\\ secondary\\)\ \(0\)\
\-\ \\Â\\·\\ pulmonary\\ arterial\\ hypertension\ \(0\)\
\-\ \\Â\\·\\ pulmonary\\ artery\\ aneurysm\\ \\(behcet\\'s\\ and\\ other\\ vasculidities\\)\ \(0\)\
\-\ this\\ is\\ a\\ 51\\-year\\-old\\ african\\-american\\ male\\ who\\ has\\ been\\ recently\\ diagnosed\\ with\\ pneumonia\\.\\ \\ he\\ also\\ presented\\ with\\ acute\\ neutropenia\\ and\\ nephrolithiasis\\,\\ currently\\ on\\ the\\ hospital\\'s\\ pneumonia\\ pathway\\.\\ \\ \ \(0\)\
\-\ past\\ medical\\ history\\:\\ \\ significant\\ for\\ chronic\\ obstructive\\ pulmonary\\ disease\\.\ \(0\)\
\-\ social\\ history\\:\\ \\ tobacco\\ use\\.\\ \\ denies\\ iv\\ drug\\ abuse\\.\ \(0\)\
\-\ common\\ findings\\ on\\ chest\\ radiograph\\ in\\ patients\\ with\\ pah\\:\ \(0\)\
\-\ enlarged\\ main\\ and\\ hilar\\ pulmonary\\ arteries\\ that\\ taper\\ rapidly\\ toward\\ the\\ periphery\ \(0\)\
\-\ enlargement\\ of\\ the\\ right\\ ventricle\\ on\\ lateral\\ view\\(obliteration\\ of\\ retrosternal\\ clear\\ space\\.\ \(0\)\
\-\ hypertension\\-induced\\ atherosclerosis\\ causes\\ calcification\\ in\\ the\\ pulmonary\\ arteries\\ \\(not\\ common\\)\ \(0\)\
\-\ criteria\\ for\\ pulmonary\\ artery\\ enlargement\\:\\ \ \(0\)\
\-\ transverse\\ diameter\\ of\\ proximal\\ interlobar\\ pulmonary\\ arteries\\ exceeding\\ 16\\ mm\\ on\\ pa\\ radiograph\ \(0\)\
\-\ right\\ interlobar\\ pa\\ greater\\ than\\ 25\\ mm\\ is\\ specific\\ for\\ primary\\ pulmonary\\ hypertension\ \(0\)\
\-\ defined\\ as\\ a\\ pulmonary\\ artery\\ systolic\\ pressure\\ greater\\ than\\ 30\\/15\\ mm\\ hg\\.\\ \ \(0\)\
\-\ the\\ etiology\\ of\\ primary\\ pulmonary\\ hypertension\\ is\\ unknown\\.\\ \ \(0\)\
\-\ secondary\\ pulmonary\\ hypertension\\ can\\ be\\ a\\ complication\\ of\\ many\\ pulmonary\\,\\ cardiac\\ and\\ extrathoracic\\ conditions\\.\\ \ \(0\)\
\-\ cor\\ pulmonale\\ is\\ enlargement\\ of\\ the\\ right\\ ventricle\\ as\\ a\\ consequence\\ of\\ disorders\\ of\\ the\\ respiratory\\ system\\.\ \(0\)\
\-\ pulmonary\\ hypertension\\ invariably\\ precedes\\ cor\\ pulmonale\\.\\ \ \(0\)\
\-\ unrelieved\\ pulmonary\\ hypertension\\,\\ regardless\\ of\\ the\\ underlying\\ cause\\,\\ leads\\ to\\ right\\ ventricular\\ failure\\.\\ \ \(0\)\
\-\ the\\ estimated\\ incidence\\ of\\ primary\\ pulmonary\\ hypertension\\ is\\ 1\\ to\\ 2\\ cases\\ per\\ 1\\ million\\ persons\\ in\\ the\\ general\\ population\\.\\ \ \(0\)\
\-\ hypoxia\\-induced\\ vasoconstriction\\ and\\ capillary\\ obliteration\\ occur\\ in\\ interstitial\\ lung\\ disease\\ and\\ chronic\\ obstructive\\ pulmonary\\ disease\\,\\ which\\ is\\ the\\ most\\ common\\ cause\\ of\\ pulmonary\\ hypertension\\.\\ \\ \\ \ \(0\)\
\-\ \\ \\ \ \(31891\)\
\-\ clinical\\ symptoms\ \(26\)\
\-\ dyspnea\\ \ \(68\)\
\-\ fatigue\\ \ \(32\)\
\-\ chest\\ pain\\ \ \(108\)\
\-\ exertional\\ syncope\\ \ \(0\)\
\-\ signs\\ of\\ right\\ heart\\ failure\\ \\(jvd\\,\\ ascites\\,\\ hepatomegaly\\)\\ \ \(0\)\
\-\ echocardiography\\ is\\ the\\ most\\ useful\\ imaging\\ modality\\ for\\ detecting\\ pulmonary\\ hypertension\\ and\\ excluding\\ underlying\\ cardiac\\ disease\\.\\ confirmation\\ of\\ pulmonary\\ hypertension\\ is\\ based\\ on\\ identification\\ of\\ tricuspid\\ regurgitation\\.\\ right\\ ventricular\\ dilatation\\ and\\ hypertrophy\\ are\\ late\\ findings\\.\\ \ \(0\)\
\-\ cardiac\\ catheterization\\ should\\ be\\ performed\\ in\\ patients\\ with\\ unexplained\\ pulmonary\\ hypertension\\ and\\ remains\\ the\\ gold\\ standard\\ for\\ its\\ diagnosis\\ and\\ quantification\\.\\ \ \(0\)\
\-\ an\\ easy\\ way\\ to\\ memorize\\ seconday\\ causes\\ of\\ pulmonary\\ artery\\ hypertension\\ is\\ through\\ the\\ mnemonic\\ vice\ \(0\)\
\-\ vasculitis\ \(67\)\
\-\ idiopathic\\ \\(pph\\)\ \(0\)\
\-\ chronic\\ emboli\\ and\\ chronic\\ lung\\ disease\ \(0\)\
\-\ emphysema\\ and\\ eisenmenger\\'s\\ syndrome\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.12080082146226113\ \(0\)\
\-\ hypertension\\:\\ 0\\.09508656196008596\ \(0\)\
\-\ \\Â\\·\\:\\ 0\\.058113552512358044\ \(0\)\
\-\ interlobar\\:\\ 0\\.029956548640510512\ \(0\)\
\-\ pulmonale\\:\\ 0\\.029956548640510512\ \(0\)\
\-\ obstructive\\:\\ 0\\.026592809371995364\ \(0\)\
\-\ cor\\:\\ 0\\.025877512706323096\ \(0\)\
\-\ artery\\:\\ 0\\.02565050395270362\ \(0\)\
\-\ chronic\\:\\ 0\\.02426400839623992\ \(0\)\
\-\ obliteration\\:\\ 0\\.023082564397613636\ \(0\)\
\-\ african\\-american\\:\\ 0\\.02225678047565391\ \(0\)\
\-\ respiratory\\:\\ 0\\.02145762256997885\ \(0\)\
\-\ arteries\\:\\ 0\\.021395587286709563\ \(0\)\
\-\ enlargement\\:\\ 0\\.020507470200514688\ \(0\)\
\-\ primary\\:\\ 0\\.020414389216900777\ \(0\)\
\-\ cardiac\\:\\ 0\\.019686512860590547\ \(0\)\
\-\ mm\\:\\ 0\\.019005212641905276\ \(0\)\
\-\ 112\\/87\\:\\ 0\\.017773222628964715\ \(0\)\
\-\ vasculidities\\:\\ 0\\.017773222628964715\ \(0\)\
\-\ hypertension\\-induced\\:\\ 0\\.017773222628964715\ \(0\)\
\-\ 30\\/15\\:\\ 0\\.017773222628964715\ \(0\)\
\-\ hypoxia\\-induced\\:\\ 0\\.017773222628964715\ \(0\)\
\-\ memorize\\:\\ 0\\.017773222628964715\ \(0\)\
\-\ pph\\:\\ 0\\.017773222628964715\ \(0\)\
\-\ disease\\:\\ 0\\.016896018643738357\ \(0\)\
\-\ emaciated\\:\\ 0\\.016375748474609986\ \(0\)\
\-\ 97\\.4\\:\\ 0\\.016375748474609986\ \(0\)\
\-\ zithromax\\:\\ 0\\.016375748474609986\ \(0\)\
\-\ precedes\\:\\ 0\\.016375748474609986\ \(0\)\
\-\ seconday\\:\\ 0\\.016375748474609986\ \(0\)\
\-\ ventricular\\:\\ 0\\.015396395766945093\ \(0\)\
\-\ arterial\\:\\ 0\\.01508203471263174\ \(0\)\
\-\ 51\\-year\\-old\\:\\ 0\\.014978274320255256\ \(0\)\
\-\ unrelieved\\:\\ 0\\.014978274320255256\ \(0\)\
\-\ quantification\\:\\ 0\\.014978274320255256\ \(0\)\
\-\ vice\\:\\ 0\\.014978274320255256\ \(0\)\
\-\ eisenmenger\\:\\ 0\\.014978274320255256\ \(0\)\
\-\ underlying\\:\\ 0\\.014767043667212576\ \(0\)\
\-\ ceftriaxone\\:\\ 0\\.014528388128089511\ \(0\)\
\-\ pah\\:\\ 0\\.014528388128089511\ \(0\)\
\-\ million\\:\\ 0\\.014528388128089511\ \(0\)\
\-\ persons\\:\\ 0\\.014528388128089511\ \(0\)\
\-\ general\\:\\ 0\\.014518478493377066\ \(0\)\
\-\ pa\\:\\ 0\\.014410368584301838\ \(0\)\
\-\ pneumonia\\:\\ 0\\.014243204416243991\ \(0\)\
\-\ behcet\\:\\ 0\\.014160804344230732\ \(0\)\
\-\ invariably\\:\\ 0\\.014160804344230732\ \(0\)\
\-\ vasoconstriction\\:\\ 0\\.014160804344230732\ \(0\)\
\-\ neutropenia\\:\\ 0\\.013850016683288679\ \(0\)\
\-\ taper\\:\\ 0\\.013850016683288679\ \(0\)\
\-\ exceeding\\:\\ 0\\.013850016683288679\ \(0\)\
\-\ excluding\\:\\ 0\\.013850016683288679\ \(0\)\
\-\ extrathoracic\\:\\ 0\\.013580800165900528\ \(0\)\
\-\ unexplained\\:\\ 0\\.013580800165900528\ \(0\)\
\-\ mnemonic\\:\\ 0\\.013580800165900528\ \(0\)\
\-\ pressure\\:\\ 0\\.013531987539606207\ \(0\)\
\-\ common\\:\\ 0\\.013525809749736273\ \(0\)\
\-\ failure\\:\\ 0\\.013497815656578092\ \(0\)\
\-\ causes\\:\\ 0\\.013413631846007305\ \(0\)\
\-\ dehydrated\\:\\ 0\\.013343334368206205\ \(0\)\
\-\ exertional\\:\\ 0\\.013343334368206205\ \(0\)\
\-\ easy\\:\\ 0\\.013130913973734783\ \(0\)\
\-\ greater\\:\\ 0\\.012942404668026214\ \(0\)\
\-\ hila\\:\\ 0\\.012938756353161548\ \(0\)\
\-\ consequence\\:\\ 0\\.012938756353161548\ \(0\)\
\-\ ventricle\\:\\ 0\\.012912864183783982\ \(0\)\
\-\ pathway\\:\\ 0\\.012763330189876002\ \(0\)\
\-\ encouraged\\:\\ 0\\.012601953763114841\ \(0\)\
\-\ retrosternal\\:\\ 0\\.012601953763114841\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.012452542528933951\ \(0\)\
\-\ tricuspid\\:\\ 0\\.012452542528933951\ \(0\)\
\-\ signs\\:\\ 0\\.012126515862846993\ \(0\)\
\-\ regardless\\:\\ 0\\.012061098951432021\ \(0\)\
\-\ 18\\.\\:\\ 0\\.011945860213851479\ \(0\)\
\-\ hg\\:\\ 0\\.011945860213851479\ \(0\)\
\-\ jvd\\:\\ 0\\.011836853719354955\ \(0\)\
\-\ enlarged\\:\\ 0\\.011756536574129058\ \(0\)\
\-\ syncope\\:\\ 0\\.011733439819380053\ \(0\)\
\-\ cause\\:\\ 0\\.01165831704254825\ \(0\)\
\-\ quickly\\:\\ 0\\.011635072552909425\ \(0\)\
\-\ stop\\:\\ 0\\.011451661709752719\ \(0\)\
\-\ \\'s\\:\\ 0\\.011395443256252288\ \(0\)\
\-\ \\:\\:\\ 0\\.011393899354744608\ \(0\)\
\-\ detecting\\:\\ 0\\.011365856035521274\ \(0\)\
\-\ gold\\:\\ 0\\.011365856035521274\ \(0\)\
\-\ is\\:\\ 0\\.011336507628724306\ \(0\)\
\-\ catheterization\\:\\ 0\\.011055068374579221\ \(0\)\
\-\ findings\\:\\ 0\\.011001029853568304\ \(0\)\
\-\ echocardiography\\:\\ 0\\.010984319745927467\ \(0\)\
\-\ radiograph\\:\\ 0\\.010975599410973235\ \(0\)\
\-\ right\\:\\ 0\\.010906835190851814\ \(0\)\
\-\ atherosclerosis\\:\\ 0\\.0108498613295995\ \(0\)\
\-\ identification\\:\\ 0\\.0108498613295995\ \(0\)\
\-\ 98\\:\\ 0\\.010663624797077291\ \(0\)\
\-\ regurgitation\\:\\ 0\\.010605182182413476\ \(0\)\
\-\ tobacco\\:\\ 0\\.010387009632735589\ \(0\)\
\-\ confirmation\\:\\ 0\\.010335965665025326\ \(0\)\
\-\ \\(\\:\\ 0\\.010194621136506096\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.01014380804445209\ \(0\)\
\-\ capillary\\:\\ 0\\.01014380804445209\ \(0\)\
\-\ way\\:\\ 0\\.010098499867331006\ \(0\)\
\-\ social\\:\\ 0\\.01005418755539799\ \(0\)\
\-\ infection\\:\\ 0\\.010016195863196803\ \(0\)\
\-\ abuse\\:\\ 0\\.010010828270678306\ \(0\)\
\-\ lung\\:\\ 0\\.009980480323543331\ \(0\)\
\-\ treatments\\:\\ 0\\.009968381881166548\ \(0\)\
\-\ estimated\\:\\ 0\\.009968381881166548\ \(0\)\
\-\ ascites\\:\\ 0\\.00988607947285958\ \(0\)\
\-\ toward\\:\\ 0\\.009807005454405384\ \(0\)\
\-\ temperature\\:\\ 0\\.009730916083472225\ \(0\)\
\-\ secondary\\:\\ 0\\.009633185348825837\ \(0\)\
\-\ periphery\\:\\ 0\\.009621909588975701\ \(0\)\
\-\ leads\\:\\ 0\\.009621909588975701\ \(0\)\
\-\ systolic\\:\\ 0\\.00958684559157274\ \(0\)\
\-\ rapidly\\:\\ 0\\.009552381008187054\ \(0\)\
\-\ compatible\\:\\ 0\\.009518495689000803\ \(0\)\
\-\ modality\\:\\ 0\\.009452387175244771\ \(0\)\
\-\ criteria\\:\\ 0\\.009420128422530172\ \(0\)\
\-\ emphysema\\:\\ 0\\.009420128422530172\ \(0\)\
\-\ emboli\\:\\ 0\\.009326338068427564\ \(0\)\
\-\ breathing\\:\\ 0\\.009266150642722563\ \(0\)\
\-\ fatigue\\:\\ 0\\.009207708028058748\ \(0\)\
\-\ than\\:\\ 0\\.009028422802089814\ \(0\)\
\-\ population\\:\\ 0\\.008989535478380859\ \(0\)\
\-\ useful\\:\\ 0\\.008989535478380859\ \(0\)\
\-\ who\\:\\ 0\\.008983743585248798\ \(0\)\
\-\ late\\:\\ 0\\.0089638519586683\ \(0\)\
\-\ remains\\:\\ 0\\.0089638519586683\ \(0\)\
\-\ patients\\:\\ 0\\.008917639513572684\ \(0\)\
\-\ pulse\\:\\ 0\\.008888708017544848\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.008864269790665121\ \(0\)\
\-\ drug\\:\\ 0\\.008840124244199967\ \(0\)\
\-\ for\\:\\ 0\\.008819856636807037\ \(0\)\
\-\ standard\\:\\ 0\\.008816264450556818\ \(0\)\
\-\ vasculitis\\:\\ 0\\.008816264450556818\ \(0\)\
\-\ smoking\\:\\ 0\\.008701025712976276\ \(0\)\
\-\ hilar\\:\\ 0\\.008656713401043261\ \(0\)\
\-\ \\)\\:\\ 0\\.008631504340080304\ \(0\)\
\-\ conditions\\:\\ 0\\.008570907726811818\ \(0\)\
\-\ complication\\:\\ 0\\.008448680666698037\ \(0\)\
\-\ interstitial\\:\\ 0\\.0084290109591469\ \(0\)\
\-\ chest\\:\\ 0\\.00824487500023193\ \(0\)\
\-\ vital\\:\\ 0\\.00824219880091564\ \(0\)\
\-\ disorders\\:\\ 0\\.00824219880091564\ \(0\)\
\-\ 1\\:\\ 0\\.008198896644998817\ \(0\)\
\-\ home\\:\\ 0\\.008189371437218011\ \(0\)\
\-\ dyspnea\\:\\ 0\\.008154906853832324\ \(0\)\
\-\ recently\\:\\ 0\\.008038719126339107\ \(0\)\
\-\ main\\:\\ 0\\.008022654268175444\ \(0\)\
\-\ afebrile\\:\\ 0\\.00795964510788491\ \(0\)\
\-\ most\\:\\ 0\\.007954980410193855\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007912174720888789\ \(0\)\
\-\ discharged\\:\\ 0\\.00789854561293465\ \(0\)\
\-\ incidence\\:\\ 0\\.00789854561293465\ \(0\)\
\-\ idiopathic\\:\\ 0\\.00785390624624672\ \(0\)\
\-\ as\\:\\ 0\\.007818009108230611\ \(0\)\
\-\ 16\\:\\ 0\\.007795884140299052\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.007781635819284752\ \(0\)\
\-\ adenopathy\\:\\ 0\\.007671135342480327\ \(0\)\
\-\ tract\\:\\ 0\\.007631210690673513\ \(0\)\
\-\ per\\:\\ 0\\.00754101735631587\ \(0\)\
\-\ admitted\\:\\ 0\\.00744265008984524\ \(0\)\
\-\ \\-\\:\\ 0\\.007386001849630498\ \(0\)\
\-\ dilatation\\:\\ 0\\.007383521833606288\ \(0\)\
\-\ on\\:\\ 0\\.007297288431103105\ \(0\)\
\-\ etiology\\:\\ 0\\.007292381840122324\ \(0\)\
\-\ denies\\:\\ 0\\.007270226353074753\ \(0\)\
\-\ defined\\:\\ 0\\.007259239246688533\ \(0\)\
\-\ diameter\\:\\ 0\\.007248311691306801\ \(0\)\
\-\ specific\\:\\ 0\\.007121602208121996\ \(0\)\
\-\ \\,\\:\\ 0\\.0070952234913805165\ \(0\)\
\-\ many\\:\\ 0\\.007081075636910126\ \(0\)\
\-\ slightly\\:\\ 0\\.006964165843260228\ \(0\)\
\-\ 25\\:\\ 0\\.006964165843260228\ \(0\)\
\-\ transverse\\:\\ 0\\.0069081586575604785\ \(0\)\
\-\ currently\\:\\ 0\\.0068269612802662446\ \(0\)\
\-\ aneurysm\\:\\ 0\\.006809353054522788\ \(0\)\
\-\ use\\:\\ 0\\.006809353054522788\ \(0\)\
\-\ system\\:\\ 0\\.006783225746775801\ \(0\)\
\-\ unknown\\:\\ 0\\.006723547380291344\ \(0\)\
\-\ rate\\:\\ 0\\.006715164295314199\ \(0\)\
\-\ malignancy\\:\\ 0\\.006657438866535314\ \(0\)\
\-\ based\\:\\ 0\\.006569940246505968\ \(0\)\
\-\ its\\:\\ 0\\.006501071458579922\ \(0\)\
\-\ hospital\\:\\ 0\\.006486081582597023\ \(0\)\
\-\ view\\:\\ 0\\.006463803687059553\ \(0\)\
\-\ occur\\:\\ 0\\.006463803687059553\ \(0\)\
\-\ appears\\:\\ 0\\.006412759719349292\ \(0\)\
\-\ clear\\:\\ 0\\.006370013332956947\ \(0\)\
\-\ diagnosed\\:\\ 0\\.006335070880635092\ \(0\)\
\-\ iv\\:\\ 0\\.00628714705133285\ \(0\)\
\-\ calcification\\:\\ 0\\.006253600037211954\ \(0\)\
\-\ male\\:\\ 0\\.006230667491481746\ \(0\)\
\-\ and\\:\\ 0\\.0061696635029187775\ \(0\)\
\-\ heart\\:\\ 0\\.005986047679251561\ \(0\)\
\-\ neoplasm\\:\\ 0\\.005867251161112758\ \(0\)\
\-\ possible\\:\\ 0\\.005802383505814661\ \(0\)\
\-\ cases\\:\\ 0\\.005739538032220025\ \(0\)\
\-\ space\\:\\ 0\\.005698703643299666\ \(0\)\
\-\ should\\:\\ 0\\.005492355931227419\ \(0\)\
\-\ past\\:\\ 0\\.005474192483762972\ \(0\)\
\-\ differential\\:\\ 0\\.005469677075308326\ \(0\)\
\-\ examination\\:\\ 0\\.005355691603779365\ \(0\)\
\-\ be\\:\\ 0\\.0053135351747739075\ \(0\)\
\-\ medical\\:\\ 0\\.005301027822713718\ \(0\)\
\-\ clinical\\:\\ 0\\.005301027822713718\ \(0\)\
\-\ days\\:\\ 0\\.005280391726153181\ \(0\)\
\-\ proximal\\:\\ 0\\.00517246609215124\ \(0\)\
\-\ treated\\:\\ 0\\.005156957330814232\ \(0\)\
\-\ two\\:\\ 0\\.004934135559709688\ \(0\)\
\-\ syndrome\\:\\ 0\\.004927231001481132\ \(0\)\
\-\ lymphoma\\:\\ 0\\.004923787569333641\ \(0\)\
\-\ through\\:\\ 0\\.0048930585048807835\ \(0\)\
\-\ he\\:\\ 0\\.0048068293186149585\ \(0\)\
\-\ performed\\:\\ 0\\.0048035853452163685\ \(0\)\
\-\ a\\:\\ 0\\.004797578247805661\ \(0\)\
\-\ history\\:\\ 0\\.004758929587528562\ \(0\)\
\-\ blood\\:\\ 0\\.004702441678446168\ \(0\)\
\-\ presented\\:\\ 0\\.004696285554480663\ \(0\)\
\-\ been\\:\\ 0\\.00468708647069353\ \(0\)\
\-\ significant\\:\\ 0\\.004632756352931902\ \(0\)\
\-\ the\\:\\ 0\\.004459654345278252\ \(0\)\
\-\ symptoms\\:\\ 0\\.004293664267939796\ \(0\)\
\-\ acute\\:\\ 0\\.004253788969972773\ \(0\)\
\-\ in\\:\\ 0\\.004247955948994505\ \(0\)\
\-\ physical\\:\\ 0\\.004226825140284754\ \(0\)\
\-\ imaging\\:\\ 0\\.004036439162208876\ \(0\)\
\-\ was\\:\\ 0\\.003984990008926157\ \(0\)\
\-\ other\\:\\ 0\\.003971045461093646\ \(0\)\
\-\ can\\:\\ 0\\.0039077063557844145\ \(0\)\
\-\ this\\:\\ 0\\.003875553279492472\ \(0\)\
\-\ of\\:\\ 0\\.003758187122515756\ \(0\)\
\-\ lateral\\:\\ 0\\.003723121059726916\ \(0\)\
\-\ 2\\:\\ 0\\.0037098880978035207\ \(0\)\
\-\ multiple\\:\\ 0\\.003628641136046913\ \(0\)\
\-\ after\\:\\ 0\\.0035645185536475857\ \(0\)\
\-\ patient\\:\\ 0\\.0034539997214370483\ \(0\)\
\-\ to\\:\\ 0\\.00344409764873376\ \(0\)\
\-\ also\\:\\ 0\\.003396410471109176\ \(0\)\
\-\ has\\:\\ 0\\.0032352821985771733\ \(0\)\
\-\ which\\:\\ 0\\.0032160173129890095\ \(0\)\
\-\ that\\:\\ 0\\.002975767597900853\ \(0\)\
\-\ not\\:\\ 0\\.002489553773673257\ \(0\)\
\-\ an\\:\\ 0\\.0023823888392837294\ \(0\)\
\-\ are\\:\\ 0\\.00234853603332581\ \(0\)\
\-\ pain\\:\\ 0\\.002104048724860352\ \(0\)\
\-\ or\\:\\ 0\\.002019199090652636\ \(0\)\
\-\ \\.\\:\\ 0\\.0016461478432237184\ \(0\)\
\-\ with\\:\\ 0\\.0014153730978615693\ \(0\)\
